Processed modern diets enriched with advanced glycation end-products (AGEs), formed by the Maillard reaction, are tempting to eat but at the same time deleterious for health (Chaudhuri et al., 2018; Nowotny et al., 2018; Zhang et al., 2020). In 1912, a French Chemist, L.C. Maillard, reported a reaction between glucose and glycine upon heating, resulting in the formation of brown pigments (Maillard, 1912). Later, the covalent bonds formed between carbohydrates and proteins during heating in a non-enzymatic browning reaction was named the Maillard reaction (Jaeger et al., 2010; Liu et al., 2020). Glycation is a part of the Maillard reaction, or browning of food, during cooking which enhances the taste, color, and aroma of the food to make it more palatable (Maillard, 1912; Lima, 2013). The Maillard reaction has revolutionized the food industry by playing an important role in food chemistry (Machiels and Istasse, 2022); however, this reaction also results in the formation of adverse AGEs as well as toxic byproducts including acrylamide (Luca et al., 2010; Mottram et al., 2022; Stadler et al., 2002).

In addition to food sources, AGEs are also endogenously produced in cells when α-dicarbonyl compounds (α-DCs) (such as glyoxal [GO], methylglyoxal [MGO], and 3-deoxyglucosone [3DG]) non-enzymatically react with biomolecules. α-DCs are unavoidable byproducts of cellular metabolisms, such as glycolysis and lipid peroxidation (Figure 1). AGEs include GO derivatives such as carboxymethyl lysine (CML) and glyoxal lysine dimer (GOLD). AGEs derived from MGO include hydroimidazolone (MG-H1), carboxyethyl lysine (CEL), and methylglyoxal lysine dimer (MOLD), and 3DG derivatives include 3-deoxyglucosone-derived imidazolium cross-link (DOGDIC), pyrraline, etc. (Chaudhuri et al., 2018; Allaman et al., 2015; Chen et al., 2018; Vistoli et al., 2013). The glyoxalase system utilizes enzymes Glo1 and Glo2 and reduced glutathione (GSH) to detoxify α-DCs stress, especially MGO to lactate (Figure 1), in cytosol and nucleus. Differential expression levels of glyoxalases are reported in various disease conditions such as diabetes, hypertension, neurodegenerative disorders, anxiety disorders, infertility, and cancer, suggesting their role in exacerbating their pathogenesis (He et al., 2020). Glo1 has been linked with several behavioral phenotypes, such as anxiety, depression, autism, and pain, among other mental illnesses (Distler and Palmer, 2012). Also, we have previously demonstrated increased neuronal damage in the Caenorhabditis elegans glod-4 glyoxalase mutant model, which is shown to accumulate high levels of α-DCs and AGEs (Figure 1 and Figure 2—figure supplement 1H, I); (Chaudhuri et al., 2016). AGEs accumulate in long-lived proteins, such as collagen (Monnier et al., 1984); furthermore, quantifying the glycated form of hemoglobin (HbA1c) is utilized as a biomarker in diabetes (Rahbar et al., 1969). Increased AGEs are associated with aging, obesity, diabetes, neurodegeneration, inflammation, cardiomyopathy, nephropathy, and other age-related diseases (Chaudhuri et al., 2018; Ramasamy et al., 2005; Prasad et al., 2019). Furthermore, neurodegenerative diseases have also demonstrated a strong correlation between increased levels of AGEs and pathogenesis.

Figure 1

Download asset Open asset

Overconsumption of food and excessive availability of cheap, highly processed foods have contributed to the obesity pandemic. Obesity is a key risk factor for other diseases including diabetes, hypertension, cancers, cardiovascular, inflammatory, and neurodegenerative disorders, among other non-communicable chronic diseases (Lee and Yau, 2020; Miller and Spencer, 2014; Wolin et al., 2010; Ellulu et al., 2017; Keramat et al., 2021; Uribarri et al., 2015; Ruhm, 2012; Hossain et al., 2007). Thus, identifying signaling pathways that modulate increased feeding behavior is important to understand the underlying causes of obesity and identify novel therapeutics to overcome it. Here, we report that loss of the glyoxalase system or exogenously feeding MGO-derived AGEs increased feeding behavior in C. elegans. We also identified the mechanism for the observed phenotype and found that the MGO-derived AGE, MG-H1, acts via the elt-3 GATA transcription factor (TF), to partially regulate the expression of tdc-1 gene (tyramine decarboxylase – an enzyme that biosynthesis neurotransmitter tyramine), and tyramine receptors (tyra-2 and ser-2) to mediate adverse effects of AGEs such as increased feeding, reduced lifespan, and neuronal damages. This study is the first to identify the signaling pathway mediated by specific AGEs molecules downstream of MGO (such as MG-H1) to enhance feeding and neurodegeneration. Our study emphasizes that AGEs accumulation is deleterious and enhances disease pathology in different conditions, including obesity and neurodegeneration. Hence, limiting AGEs accumulation is relevant to the global increase in obesity and other age-associated diseases.

Our observation that glod-4 mutants run out of bacterial lawn faster than wildtype N2 animals during routine maintenance led to the elucidation of a novel signaling pathway that mediates AGE-induced feeding behavior in C. elegans. Glyoxalases are enzymes involved in the detoxification of α-DCs (Figure 1), and we have previously characterized glod-4 mutant, which lacks one of the glyoxalase enzymes, to accumulate increased levels of α-DCs (Chaudhuri et al., 2016) and thereby AGEs, especially MG-H1 (Figure 2—figure supplement 1H, I). In this study, using genetic mutants, RNAi knockdown, synthesized AGEs, and functional genomics, we elucidate that AGEs (especially MG-H1) induce increased feeding through tyramine signaling regulated by GATA transcription factor ELT-3. The glod-4 KO worms, with enhance AGEs accumulation, showed increased feeding, which led to the hypothesis that increased accumulation of AGEs is a potential stimulator of binge feeding. Thus, we studied changes in pumping rate by exogenous administration of MGO and AGEs. As previously reported by Ravichandran et al., 2018, MGO treatment did not change the pumping rate; however, MG-H1 and CEL increased the pumping rate in wildtype N2 worms (Figure 2—figure supplement 1E; Ravichandran et al., 2018). Furthermore, a recent study demonstrated that treatment with sugar-derived AGE-modified bovine serum albumin accelerated the pharyngeal pumping rate (Papaevgeniou et al., 2019). Our study demonstrates that either treatment with purified MG-H1 or endogenous production and accumulation of MG-H1 via genetic mutation increases feeding and adversely affects lifespan. We also found that MG-H1-induced hyper-feeding is independent of serotonin-mediated hyper-feeding (Dallière et al., 2017) in C. elegans (Figure 2—figure supplement 1B–D).

Our detailed investigation of the time-dependent increase in pumping rate after MG-H1 treatment indicates a more robust and highly significant increase after 24 hr of treatment (Figure 2C). We also observed a MG-H1 dose-dependent increase in feeding rate (Figure 2E), which is based on the stronger significance (lower p-value) caused by reduced dispersion of the data at higher concentrations of MG-H1. Our analysis indicates that higher concentrations of MG-H1 can increase the pharyngeal pumping in almost all the treatment worms, thus predisposing the worms with lower pumping rates in the Gaussian distribution to higher pumping rates. It is well established that AGEs are formed during cooking, browning the food during dry heating, making the food more appetizing (Vistoli et al., 2013). Furthermore, feeding is a multisensorial process regulated by several signaling pathways subjected to evolutionary adaptations (Luca et al., 2010). Thus, we wanted to analyze the changes in sensory behavior of C. elegans induced by either endogenous accumulation of AGEs or by exogenous administration of MG-H1 with the food. Since the glod-4 mutant lacks glyoxalase system to detoxify MGO and leads to the accumulation of AGEs (Figure 1), the MG-H1-mediated signaling pathway can be responsible for the increased chemoattraction of glod-4 mutant worms to food source OP50-1 (Figure 2F). It can be explained that including MG-H1 in bacterial lawn increased the chemoattraction of wildtype N2 worms toward food, resulting in increased attraction to palatable MG-H1-mixed bacterial food OP50-1 (Figure 2G). However, unlike wildtype N2 worms, exogenous MG-H1 treatment had no further increase in the feeding rate or chemoattraction of glod-4 mutant worms (Figure 2D, H and Figure 2—figure supplement 1F), indicating the maximum sensory modulation attained by the endogenous accumulation of MG-H1 in the glod-4 mutant. Although our screening identified CEL, a lysine-derived adduct of MGO, as another AGEs increasing the food intake, a detailed analysis is necessary to conclude the effect of CEL on feeding behavior (Figure 2—figure supplement 1E).

We utilized RNAseq data from glod-4 knockdown worms to identify the novel signaling pathway that mediates AGE-induced feeding in C. elegans. Since glod-4 knockdown data are enriched with several genes regulating the synthesis of neurotransmitters and feeding (Figure 3A and Figure 3—figure supplement 1), we performed suppression screening in mutant worms for genes involved in synthesizing biogenic amine neurotransmitters after MG-H1 treatment (Figure 3B and Figure 3—figure supplement 2A, C). Thus, our screen identified tdc-1, involved in tyramine biosynthesis, and tyramine receptors (tyra-2 and ser-2) to mediate AGE-induced increased pharyngeal pumping (Figure 3C–F and Figure 3—figure supplement 2). Tryptophan and tyrosine are the substrates for synthesizing biogenic amines implicated in modulating various behaviors in C. elegans (Chase and Koelle, 2007; Alkema et al., 2005). Tyrosine to tyramine conversion in the presence of the enzyme tyrosine decarboxylase (TDC-1) followed by tyramine β-hydroxylase (TBH-1), is crucial for the synthesis of neurotransmitters tyramine and octopamine, respectively (Alkema et al., 2005; Greer et al., 2008). Previous studies have shown the role of tyramine and its receptor (ser-2) in regulating feeding and foraging behavior in C. elegans (Dallière et al., 2017; Greer et al., 2008; Rex et al., 2004; Li et al., 2012). Furthermore, the tyra-2 receptor is expressed in MC (Marginal Cell) and NSM (NeuroSecretory Motor) pharyngeal neurons and is discussed to regulate pharyngeal pumping potentially (Dallière et al., 2017; Rex et al., 2005). Especially, tyramine has been shown to reduce pharyngeal pumping when applied exogenously to the worms (Figure 5A; Dallière et al., 2017). Supporting previous findings (Dallière et al., 2017), our observation shows increased pharyngeal pumping in tyra-2 and ser-2 single mutant worms (Figure 3E, F); at the same time, tdc-1 single mutants did not increase pumping (Figure 3D). Converse to our observation of tyra-2 and ser-2 single mutants, Greer et al., 2008 did not find any difference in the pumping rate of tyra-2 and ser-2 single mutants compared to wildtype N2 worms. However, the same study reported no changes in the pumping rate of the tdc-1 single mutant, similar to our results (Greer et al., 2008), which is also demonstrated by Li et al., 2012. Interestingly, double mutants of either tdc-1 or its receptors (tyra-2-partial suppression and ser-2) with glod-4 mutant significantly suppress the increased pharyngeal pumping observed in either glod-4 or tyra-2 or ser-2 single mutants (Figure 3D–F). It is to be noted that only two interneurons, namely RIM (Ring Interneuron M) and RIC (Ring Interneuron C) neurons, uv1 cells near vulva and gonadal sheath cells (Alkema et al., 2005) express the tdc-1 gene, which is involved in the biosynthesis of tyramine; however, receptors of tyramine are expressed in distant tissues explaining an endocrine activity for tyramine neurotransmitter (Dallière et al., 2017) leading to the multi-pathway mode of action to exert differential response which should be elucidated in the future. Since ser-3 mutant worms did not suppress the pumping (Figure 3—figure supplement 2C) and ser-3 has been demonstrated to be a receptor for octopamine (Dallière et al., 2017), we conclude that octopamine is not responsible for mediating MG-H1-induced feeding in C. elegans.

Our suppressor screen for the upstream effector of the tdc-1-tyramine-tyra-2/ser-2 pathway that mediates MG-H1-induced increased feeding identified the elt-3 TF (Figure 4C, D). Thus, we examined whether elt-3 TF regulates the tdc-1, tyra-2, or ser-2. Our analysis revealed that in elt-3 mutant worms, the tdc-1 gene is significantly reduced (Figure 4E), concluding that elt-3 TF regulates tyramine biosynthesis. In favor of the data, HOMER analysis identified that the tdc-1 gene is potentially regulated by elt-3 TF (Figure 4—figure supplement 1C). Although elt-3 TF is predominantly expressed in hypodermal cells, its expression is also reported in the pharyngeal–intestinal valve, intestine, a few neurons (head neurons and mechanosensory PVD (Posterior Ventral process D) neuron), etc. (Wormbase.org). In accordance with elt-3 expression in PVD neurons and head neurons, tyra-2 is also expressed in PVD neurons (Rex et al., 2005) and tdc-1 in RIM and RIC head interneurons, respectively, suggesting a possible direct/partial regulation of tdc-1 expression by elt-3. Also, tyra-2 expression has been reported in pharyngeal MC neurons, which directly regulate pharyngeal pumping (Rex et al., 2005), suggesting direct endocrine action of tyramine. Similarly, ser-2 is expressed in pharyngeal muscle segment cells (Rex et al., 2004; Li et al., 2012; Tsalik et al., 2003). Increased expression of ser-2 in elt-3 mutant worms can be inferred as a compensatory mechanism for reduced tyramine signaling by increasing the expression of the tyramine receptor. Also, ser-2 expression is significantly increased in MG-H1 treated wildtype N2 worms (Figure 4F). Although the mechanism of MG-H1-induced expression of ser-2 is unclear, it is evident that the ser-2 genetic mutant can suppress the increased feeding in the glod-4 mutant (double mutants) (Figure 3F), demonstrating an important role of the SER-2 receptor in mediating the MG-H1-induced feeding via tyramine. Furthermore, elt-3 expression levels significantly increased after MG-H1 treatment. Altogether, our data strongly suggest the role of the elt-3-tdc-1-tyramine-tyra-2/ser-2 pathway in mediating enhanced feeding. Finally, it is essential to note that the ser-2 gene is upregulated in the glod-4 knockdown RNAseq dataset, similar to significant upregulation after MG-H1 treatment, validating that MG-H1 is a critical player in mediating adverse phenotypes observed in glod-4 mutant worms.

Exogenous tyramine suppressed pharyngeal pumping in N2 wildtype worms; however, tyramine rescued the pumping in double mutants (elt-3;glod-4 and tdc-1;glod-4) to that of glod-4 single mutants (Figure 5). Although our data strongly demonstrate the role of tyramine signaling in increasing feeding rate in glod-4 mutant background, our study also identified a paradox in tyramine signaling to regulated pharyngeal pumping. From the literature (Dallière et al., 2017) as well as from our data, it is evident that tyramine suppresses pumping in N2 wildtype genetic background (Figure 5A). The mechanism behind this behavioral switch, that is, from suppressor of pharyngeal pumping in wildtype to a stimulator in glod-4 mutant background, remains elusive. It can be speculated that MG-H1 can modify the tissue-specific expression of tyramine receptors (Figure 4F), resulting in an observed behavioral switch in response to tyramine signaling. This hypothesis can only be addressed by methodologies such as single-cell RNA sequencing and exploration of cellular signaling circuitry in further studies. Thus, our current understanding is that MG-H1 (either exogenous or endogenous accumulation in glod-4 KO) modifies tyramine signaling by modulating genes in the tyramine pathway, leading to an increased feeding rate in C. elegans.

Previously, we have demonstrated reduced lifespan, hyperesthesia, and accelerated neurodegeneration-like phenotypes observed in diabetic conditions caused by excessive accumulation of α-DCs in glod-4 mutant worms (Chaudhuri et al., 2016). Lack of dicarbonyl detoxification by glyoxalases enzyme in glod-4 mutant worms (Figure 1) should result in the accumulation of AGEs (Figure 2—figure supplement 1H, I), which at sufficient concentration act as signaling molecules to modulate the feeding behavior (Figure 2) by causing differential gene expression (Figure 3). The increased amount of dicarbonyl stress, thereby AGEs, is observed in several systemic diseases such as obesity, diabetes, cardiovascular and neurodegenerative diseases, among other age-associated diseases (Chaudhuri et al., 2018). In diabetic patients, three times higher plasma levels of MGO have been reported and is a leading cause of neuropathic pain (Bierhaus et al., 2012; Rabbani and Thornalley, 2014; Kold-Christensen et al., 2019). Earlier reports in the literature show that the dicarbonyl levels correlate with diabetic complications. One of the major risk factors for diabetes is obesity (Ismail et al., 2021), which is caused by overfeeding. Thus, exploring the regulatory pathways of feeding is essential to understand and identify ways to modulate feeding behavior.

Here, we show that AGEs can modulate feeding behavior in evolutionary primitive model organisms, and it will be worth exploring this pathway in mammals. The TF elt-3 belongs to the GATA TF family (Gilleard et al., 1999). Shobatake et al., 2018 report that GATA 2 and 3 TFs induce the expression of appetite regulator genes such as POMC and CART (Shobatake et al., 2018). With the easy availability and unlimited access to modern-day processed food enriched in sugars and AGEs resulting in overeating, a significant cause of the obesity pandemic, it is necessary to explore signals regulating feeding. Importantly, our study shows exogenous treatment with MG-H1 increases feeding in worms (Figure 2C, D), indicating that a high AGEs diet in our day-to-day life can modulate feeding behavior in humans. It is well known that food cooked by grilling, broiling, roasting, searing, and frying accelerates the formation of AGEs in food; thus, methods are explored to cook food with fewer AGEs accumulation (Uribarri et al., 2010). Furthermore, increased caloric intake and changes in eating habits have been reported in a behavioral variant of frontotemporal dementia (Aiello et al., 2016) and medication of antipsychotic drugs (Perez-Gomez et al., 2018).

Finally, we show that a lack of tdc-1-tyramine signaling rescues glod-4 mutant phenotypes (lifespan and neuronal damage) (Figure 6). A strong association between worsening PD phenotypes with increased aggregation of α-synuclein and specific sites of increased glycation has been demonstrated in different genetic models with increased AGEs (Vicente Miranda et al., 2017). Thus, it will be interesting to investigate the role of the tdc-1-tyramine pathway in modulating pathways enhancing neurodegeneration and feeding. Recent research identified neurodegenerative diseases to be influenced by metabolism (Muddapu et al., 2020; Procaccini et al., 2016) and glod-4 mutants demonstrate increased neuronal damage, decreased lifespan, and increased feeding. Thus, it is essential to investigate the balance in energy metabolism to identify critical pathways to modulate the outcome of neurodegenerative diseases.

All data generated during this study are included in the manuscript. The RNAseq data is included as supplementary file.

1. 1. Aiello M
   2. Silani V
   3. Rumiati RI

   (2016) You stole my food! Eating alterations in frontotemporal dementia

   Neurocase 22:400–409.

   https://doi.org/10.1080/13554794.2016.1197952

   • PubMed
   • Google Scholar
2. 1. Alkema MJ
   2. Hunter-Ensor M
   3. Ringstad N
   4. Horvitz HR

   (2005) Tyramine Functions independently of octopamine in the Caenorhabditis elegans nervous system

   Neuron 46:247–260.

   https://doi.org/10.1016/j.neuron.2005.02.024

   • PubMed
   • Google Scholar
3. 1. Allaman I
   2. Bélanger M
   3. Magistretti PJ

   (2015) Methylglyoxal, the dark side of glycolysis

   Frontiers in Neuroscience 9:23.

   https://doi.org/10.3389/fnins.2015.00023

   • PubMed
   • Google Scholar
4. 1. Avery L
   2. Horvitz HR

   (1990) Effects of starvation and neuroactive drugs on feeding in Caenorhabditis elegans

   The Journal of Experimental Zoology 253:263–270.

   https://doi.org/10.1002/jez.1402530305

   • PubMed
   • Google Scholar
5. 1. Bierhaus A
   2. Fleming T
   3. Stoyanov S
   4. Leffler A
   5. Babes A
   6. Neacsu C
   7. Sauer SK
   8. Eberhardt M
   9. Schnölzer M
   10. Lasitschka F
   11. Neuhuber WL
   12. Kichko TI
   13. Konrade I
   14. Elvert R
   15. Mier W
   16. Pirags V
   17. Lukic IK
   18. Morcos M
   19. Dehmer T
   20. Rabbani N
   21. Thornalley PJ
   22. Edelstein D
   23. Nau C
   24. Forbes J
   25. Humpert PM
   26. Schwaninger M
   27. Ziegler D
   28. Stern DM
   29. Cooper ME
   30. Haberkorn U
   31. Brownlee M
   32. Reeh PW
   33. Nawroth PP

   (2012) Methylglyoxal modification of Nav1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy

   Nature Medicine 18:926–933.

   https://doi.org/10.1038/nm.2750

   • PubMed
   • Google Scholar
6. 1. Bijwadia SR
   2. Morton K
   3. Meyer JN

   (2021) Quantifying levels of dopaminergic neuron morphological alteration and degeneration in Caenorhabditis elegans

   Journal of Visualized Experiments 20:62894.

   https://doi.org/10.3791/62894

   • PubMed
   • Google Scholar
7. 1. Chase DL
   2. Koelle MR

   (2007)

   WormBook

   1–15, Biogenic amine neurotransmitters in C. elegans, WormBook, WormBook, 10.1895/wormbook.1.132.1, 18050501.

   • Google Scholar
8. 1. Chaudhuri J
   2. Bose N
   3. Gong J
   4. Hall D
   5. Rifkind A
   6. Bhaumik D
   7. Peiris TH
   8. Chamoli M
   9. Le CH
   10. Liu J
   11. Lithgow GJ
   12. Ramanathan A
   13. Xu XZS
   14. Kapahi P

   (2016) A Caenorhabditis elegans model Elucidates a conserved role for TRPA1-Nrf Signaling in reactive α-Dicarbonyl Detoxification

   Current Biology 26:3014–3025.

   https://doi.org/10.1016/j.cub.2016.09.024

   • PubMed
   • Google Scholar
9. 1. Chaudhuri J
   2. Bains Y
   3. Guha S
   4. Kahn A
   5. Hall D
   6. Bose N
   7. Gugliucci A
   8. Kapahi P

   (2018) The role of advanced glycation end products in aging and metabolic diseases: Bridging association and causality

   Cell Metabolism 28:337–352.

   https://doi.org/10.1016/j.cmet.2018.08.014

   • PubMed
   • Google Scholar
10. 1. Chen JH
    2. Lin X
    3. Bu C
    4. Zhang X

    (2018) Role of advanced glycation end products in mobility and considerations in possible dietary and nutritional intervention strategies

    Nutrition & Metabolism 15:72.

    https://doi.org/10.1186/s12986-018-0306-7

    • PubMed
    • Google Scholar
11. 1. Dallière N
    2. Holden-Dye L
    3. Dillon J
    4. O’Connor V
    5. Walker RJ

    (2017)

    Oxford Research Encyclopedia of Neuroscience

    Caenorhabditis elegans feeding behaviors, Oxford Research Encyclopedia of Neuroscience, Neuroscience.

    • Google Scholar
12. 1. Distler MG
    2. Palmer AA

    (2012) Role of Glyoxalase 1 (Glo1) and methylglyoxal (MG) in behavior: recent advances and mechanistic insights

    Frontiers in Genetics 3:250.

    https://doi.org/10.3389/fgene.2012.00250

    • PubMed
    • Google Scholar
13. 1. Ellulu MS
    2. Patimah I
    3. Khaza’ai H
    4. Rahmat A
    5. Abed Y

    (2017) Obesity and inflammation: the linking mechanism and the complications

    Archives of Medical Science 13:851–863.

    https://doi.org/10.5114/aoms.2016.58928

    • PubMed
    • Google Scholar
14. 1. Gilleard JS
    2. Shafi Y
    3. Barry JD
    4. McGhee JD

    (1999) ELT-3: A Caenorhabditis elegans GATA factor expressed in the embryonic epidermis during morphogenesis

    Developmental Biology 208:265–280.

    https://doi.org/10.1006/dbio.1999.9202

    • PubMed
    • Google Scholar
15. 1. Golegaonkar S
    2. Tabrez SS
    3. Pandit A
    4. Sethurathinam S
    5. Jagadeeshaprasad MG
    6. Bansode S
    7. Sampathkumar S-G
    8. Kulkarni MJ
    9. Mukhopadhyay A

    (2015) Rifampicin reduces advanced glycation end products and activates DAF-16 to increase lifespan in Caenorhabditis elegans

    Aging Cell 14:463–473.

    https://doi.org/10.1111/acel.12327

    • PubMed
    • Google Scholar
16. 1. Greer ER
    2. Pérez CL
    3. Van Gilst MR
    4. Lee BH
    5. Ashrafi K

    (2008) Neural and molecular dissection of a C. elegans sensory circuit that regulates fat and feeding

    Cell Metabolism 8:118–131.

    https://doi.org/10.1016/j.cmet.2008.06.005

    • PubMed
    • Google Scholar
17. 1. Gross AD
    2. Coats JR
    3. Duke SO
    4. Seiber JN

    (2014)

    G-Protein-Coupled Receptors (GPCRs) as Biopesticide Targets: A Focus on Octopamine and Tyramine Receptors

    45–56, Biopesticides: state of the art and future opportunities, G-Protein-Coupled Receptors (GPCRs) as Biopesticide Targets: A Focus on Octopamine and Tyramine Receptors, Washington, DC, ACS Poblications, 10.1021/bk-2014-1172.

    • Google Scholar
18. 1. Hashimoto C
    2. Iwaihara Y
    3. Chen SJ
    4. Tanaka M
    5. Watanabe T
    6. Matsui T

    (2013) Highly-Sensitive detection of free advanced Glycation End-products by Liquid Chromatography-Electrospray Ionization-Tandem Mass Spectrometry with 2,4,6-Trinitrobenzene Sulfonate derivatization

    Analytical Chemistry 85:4289–4295.

    https://doi.org/10.1021/ac400294q

    • Google Scholar
19. 1. He Y
    2. Zhou C
    3. Huang M
    4. Tang C
    5. Liu X
    6. Yue Y
    7. Diao Q
    8. Zheng Z
    9. Liu D

    (2020) Glyoxalase system: A systematic review of its biological activity, related-diseases, screening methods and small molecule regulators

    Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie 131:110663.

    https://doi.org/10.1016/j.biopha.2020.110663

    • PubMed
    • Google Scholar
20. 1. Hellwig M
    2. Geissler S
    3. Matthes R
    4. Peto A
    5. Silow C
    6. Brandsch M
    7. Henle T

    (2011) Transport of free and peptide-bound glycated amino acids: synthesis, transepithelial flux at Caco-2 cell monolayers, and interaction with apical membrane transport proteins

    Chembiochem 12:1270–1279.

    https://doi.org/10.1002/cbic.201000759

    • PubMed
    • Google Scholar
21. 1. Hossain P
    2. Kawar B
    3. El Nahas M

    (2007) Obesity and diabetes in the developing world--a growing challenge

    The New England Journal of Medicine 356:213–215.

    https://doi.org/10.1056/NEJMp068177

    • PubMed
    • Google Scholar
22. 1. Ismail L
    2. Materwala H
    3. Al Kaabi J

    (2021) Association of risk factors with type 2 diabetes: A systematic review

    Computational and Structural Biotechnology Journal 19:1759–1785.

    https://doi.org/10.1016/j.csbj.2021.03.003

    • PubMed
    • Google Scholar
23. 1. Jaeger H
    2. Janositz A
    3. Knorr D

    (2010) The Maillard reaction and its control during food processing: the potential of emerging technologies

    Pathologie-Biologie 58:207–213.

    https://doi.org/10.1016/j.patbio.2009.09.016

    • PubMed
    • Google Scholar
24. 1. Ji Ying Sze MV
    2. Loer C
    3. Shi Y
    4. Ruvkun G

    (2000) Food and metabolic signalling defects in a Caenorhabditis elegans serotonin-synthesis mutant

    Nature 403:560–564.

    https://doi.org/10.1038/35000609

    • Google Scholar
25. 1. Keramat SA
    2. Alam K
    3. Rana RH
    4. Chowdhury R
    5. Farjana F
    6. Hashmi R
    7. Gow J
    8. Biddle SJH

    (2021) Obesity and the risk of developing chronic diseases in middle-aged and older adults: Findings from an Australian longitudinal population survey, 2009-2017

    PLOS ONE 16:e0260158.

    https://doi.org/10.1371/journal.pone.0260158

    • PubMed
    • Google Scholar
26. 1. Kold-Christensen R
    2. Jensen KK
    3. Smedegård-Holmquist E
    4. Sørensen LK
    5. Hansen J
    6. Jørgensen KA
    7. Kristensen P
    8. Johannsen M

    (2019) ReactELISA method for quantifying methylglyoxal levels in plasma and cell cultures

    Redox Biology 26:101252.

    https://doi.org/10.1016/j.redox.2019.101252

    • PubMed
    • Google Scholar
27. 1. Lee THY
    2. Yau SY

    (2020) From obesity to hippocampal neurodegeneration: pathogenesis and non-pharmacological interventions

    International Journal of Molecular Sciences 22:201.

    https://doi.org/10.3390/ijms22010201

    • PubMed
    • Google Scholar
28. 1. Li Z
    2. Li Y
    3. Yi Y
    4. Huang W
    5. Yang S
    6. Niu W
    7. Zhang L
    8. Xu Z
    9. Qu A
    10. Wu Z
    11. Xu T

    (2012) Dissecting a central flip-flop circuit that integrates contradictory sensory cues in C. elegans feeding regulation

    Nature Communications 3:776.

    https://doi.org/10.1038/ncomms1780

    • PubMed
    • Google Scholar
29. Book

    1. Lima M

    (2013)

    Encyclopedia of Biological Chemistry

    Elsevier.

    • Google Scholar
30. 1. Liu X
    2. Xia B
    3. Hu L
    4. Ni Z
    5. Thakur K
    6. Wei Z

    (2020) Maillard conjugates and their potential in food and nutritional industries: A review

    Food Frontiers 1:382–397.

    https://doi.org/10.1002/fft2.43

    • Google Scholar
31. 1. Luca F
    2. Perry GH
    3. Di Rienzo A

    (2010) Evolutionary adaptations to dietary changes

    Annual Review of Nutrition 30:291–314.

    https://doi.org/10.1146/annurev-nutr-080508-141048

    • PubMed
    • Google Scholar
32. 1. Machiels D
    2. Istasse L

    (2022)

    Maillard reaction: importance and applications in food chemistry

    Annales de Médecine Vétérinaire 146:347–352.

    • Google Scholar
33. 1. Maillard LC

    (1912)

    Action des acides amines sur les sucres: formation des melanoidines par voie methodique

    Comptes Rendus de l’Académie Des Sciences 154:66–68.

    • Google Scholar
34. 1. Mango SE
    2. Lambie EJ
    3. Kimble J

    (1994)

    The pha-4 gene is required to generate the pharyngeal primordium of Caenorhabditis elegans

    Development 120:3019–3031.

    • Google Scholar
35. 1. Mango SE

    (2007)

    WormBook

    1–26, The C. elegans pharynx: a model for organogenesis, WormBook, WormBook, 10.1895/wormbook.1.129.1, 18050503.

    • Google Scholar
36. 1. Miller AA
    2. Spencer SJ

    (2014) Obesity and neuroinflammation: a pathway to cognitive impairment

    Brain, Behavior, and Immunity 42:10–21.

    https://doi.org/10.1016/j.bbi.2014.04.001

    • PubMed
    • Google Scholar
37. 1. Monnier VM
    2. Kohn RR
    3. Cerami A

    (1984) Accelerated age-related browning of human collagen in diabetes mellitus

    PNAS 81:583–587.

    https://doi.org/10.1073/pnas.81.2.583

    • PubMed
    • Google Scholar
38. 1. Morcos M
    2. Du X
    3. Pfisterer F
    4. Hutter H
    5. Sayed AAR
    6. Thornalley P
    7. Ahmed N
    8. Baynes J
    9. Thorpe S
    10. Kukudov G
    11. Schlotterer A
    12. Bozorgmehr F
    13. El Baki RA
    14. Stern D
    15. Moehrlen F
    16. Ibrahim Y
    17. Oikonomou D
    18. Hamann A
    19. Becker C
    20. Zeier M
    21. Schwenger V
    22. Miftari N
    23. Humpert P
    24. Hammes HP
    25. Buechler M
    26. Bierhaus A
    27. Brownlee M
    28. Nawroth PP

    (2008) Glyoxalase-1 prevents mitochondrial protein modification and enhances lifespan in Caenorhabditis elegans

    Aging Cell 7:260–269.

    https://doi.org/10.1111/j.1474-9726.2008.00371.x

    • PubMed
    • Google Scholar
39. 1. Mottram DS
    2. Wedzicha BL
    3. Dodson AT

    (2022) Acrylamide is formed in the Maillard reaction

    Nature 419:448–449.

    https://doi.org/10.1038/419448a

    • Google Scholar
40. 1. Muddapu VR
    2. Dharshini SAP
    3. Chakravarthy VS
    4. Gromiha MM

    (2020) Neurodegenerative diseases - is metabolic deficiency the root cause?

    Frontiers in Neuroscience 14:213.

    https://doi.org/10.3389/fnins.2020.00213

    • PubMed
    • Google Scholar
41. 1. Nowotny K
    2. Schröter D
    3. Schreiner M
    4. Grune T

    (2018) Dietary advanced glycation end products and their relevance for human health

    Ageing Research Reviews 47:55–66.

    https://doi.org/10.1016/j.arr.2018.06.005

    • PubMed
    • Google Scholar
42. 1. Nyamsuren O
    2. Faggionato D
    3. Loch W
    4. Schulze E
    5. Baumeister R

    (2007) A mutation in CHN-1/CHIP suppresses muscle degeneration in Caenorhabditis elegans

    Developmental Biology 312:193–202.

    https://doi.org/10.1016/j.ydbio.2007.09.033

    • PubMed
    • Google Scholar
43. 1. Papaevgeniou N
    2. Hoehn A
    3. Tur JA
    4. Klotz L-O
    5. Grune T
    6. Chondrogianni N

    (2019) Sugar-derived AGEs accelerate pharyngeal pumping rate and increase the lifespan of Caenorhabditis elegans

    Free Radical Research 53:1056–1067.

    https://doi.org/10.1080/10715762.2019.1661403

    • PubMed
    • Google Scholar
44. 1. Perez-Gomez A
    2. Carretero M
    3. Weber N
    4. Peterka V
    5. To A
    6. Titova V
    7. Solis G
    8. Osborn O
    9. Petrascheck M

    (2018) A phenotypic Caenorhabditis elegans screen identifies A selective suppressor of antipsychotic-induced hyperphagia

    Nature Communications 9:5272.

    https://doi.org/10.1038/s41467-018-07684-y

    • PubMed
    • Google Scholar
45. 1. Pirri JK
    2. McPherson AD
    3. Donnelly JL
    4. Francis MM
    5. Alkema MJ

    (2009) A tyramine-gated chloride channel coordinates distinct motor programs of A Caenorhabditis elegans escape response

    Neuron 62:526–538.

    https://doi.org/10.1016/j.neuron.2009.04.013

    • PubMed
    • Google Scholar
46. 1. Prasad C
    2. Davis KE
    3. Imrhan V
    4. Juma S
    5. Vijayagopal P

    (2019) Advanced glycation end products and risks for chronic diseases: Intervening through lifestyle modification

    American Journal of Lifestyle Medicine 13:384–404.

    https://doi.org/10.1177/1559827617708991

    • PubMed
    • Google Scholar
47. 1. Procaccini C
    2. Santopaolo M
    3. Faicchia D
    4. Colamatteo A
    5. Formisano L
    6. de Candia P
    7. Galgani M
    8. De Rosa V
    9. Matarese G

    (2016) Role of metabolism in neurodegenerative disorders

    Metabolism 65:1376–1390.

    https://doi.org/10.1016/j.metabol.2016.05.018

    • PubMed
    • Google Scholar
48. 1. Rabbani N
    2. Thornalley PJ

    (2014) Measurement of methylglyoxal by stable isotopic dilution analysis LC-MS/MS with corroborative prediction in physiological samples

    Nature Protocols 9:1969–1979.

    https://doi.org/10.1038/nprot.2014.129

    • PubMed
    • Google Scholar
49. 1. Rahbar S
    2. Blumenfeld O
    3. Ranney HM

    (1969) Studies of an unusual hemoglobin in patients with diabetes mellitus

    Biochemical and Biophysical Research Communications 36:838–843.

    https://doi.org/10.1016/0006-291x(69)90685-8

    • PubMed
    • Google Scholar
50. 1. Raizen D
    2. Song BM
    3. Trojanowski N
    4. You YJ

    (2012) Methods for measuring pharyngeal behaviors

    WormBook 18:1–13.

    https://doi.org/10.1895/wormbook.1.154.1

    • PubMed
    • Google Scholar
51. 1. Ramasamy R
    2. Vannucci SJ
    3. Yan SSD
    4. Herold K
    5. Yan SF
    6. Schmidt AM

    (2005) Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation

    Glycobiology 15:16R–28R.

    https://doi.org/10.1093/glycob/cwi053

    • PubMed
    • Google Scholar
52. 1. Ravichandran M
    2. Priebe S
    3. Grigolon G
    4. Rozanov L
    5. Groth M
    6. Laube B
    7. Guthke R
    8. Platzer M
    9. Zarse K
    10. Ristow M

    (2018) Impairing L-threonine catabolism promotes healthspan through methylglyoxal-mediated proteohormesis

    Cell Metabolism 27:914–925.

    https://doi.org/10.1016/j.cmet.2018.02.004

    • PubMed
    • Google Scholar
53. 1. Rex E
    2. Molitor SC
    3. Hapiak V
    4. Xiao H
    5. Henderson M
    6. Komuniecki R

    (2004) Tyramine receptor (SER-2) isoforms are involved in the regulation of pharyngeal pumping and foraging behavior in Caenorhabditis elegans

    Journal of Neurochemistry 91:1104–1115.

    https://doi.org/10.1111/j.1471-4159.2004.02787.x

    • PubMed
    • Google Scholar
54. 1. Rex E
    2. Hapiak V
    3. Hobson R
    4. Smith K
    5. Xiao H
    6. Komuniecki R

    (2005) TYRA-2 (F01E11.5): a Caenorhabditis elegans tyramine receptor expressed in the MC and NSM pharyngeal neurons

    Journal of Neurochemistry 94:181–191.

    https://doi.org/10.1111/j.1471-4159.2005.03180.x

    • PubMed
    • Google Scholar
55. 1. Ruhm CJ

    (2012) Understanding overeating and obesity

    Journal of Health Economics 31:781–796.

    https://doi.org/10.1016/j.jhealeco.2012.07.004

    • PubMed
    • Google Scholar
56. 1. Shobatake R
    2. Takasawa K
    3. Ota H
    4. Itaya-Hironaka A
    5. Yamauchi A
    6. Sakuramoto-Tsuchida S
    7. Uchiyama T
    8. Makino M
    9. Sugie K
    10. Takasawa S
    11. Ueno S

    (2018) Up-regulation of POMC and CART mRNAs by intermittent hypoxia via GATA transcription factors in human neuronal cells

    The International Journal of Biochemistry & Cell Biology 95:100–107.

    https://doi.org/10.1016/j.biocel.2017.12.012

    • PubMed
    • Google Scholar
57. 1. Stadler RH
    2. Blank I
    3. Varga N
    4. Robert F
    5. Hau J
    6. Guy PA
    7. Robert MC
    8. Riediker S

    (2002) Acrylamide from Maillard reaction products

    Nature 419:449–450.

    https://doi.org/10.1038/419449a

    • PubMed
    • Google Scholar
58. 1. Thornalley PJ
    2. Langborg A
    3. Minhas HS

    (1999)

    Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose

    The Biochemical Journal 344 Pt 1:109–116.

    • PubMed
    • Google Scholar
59. 1. Trojanowski NF
    2. Raizen DM
    3. Fang-Yen C

    (2016) Pharyngeal pumping in Caenorhabditis elegans depends on tonic and phasic signaling from the nervous system

    Scientific Reports 6:22940.

    https://doi.org/10.1038/srep22940

    • PubMed
    • Google Scholar
60. 1. Tsalik EL
    2. Niacaris T
    3. Wenick AS
    4. Pau K
    5. Avery L
    6. Hobert O

    (2003) LIM homeobox gene-dependent expression of biogenic amine receptors in restricted regions of the C. elegans nervous system

    Developmental Biology 263:81–102.

    https://doi.org/10.1016/s0012-1606(03)00447-0

    • PubMed
    • Google Scholar
61. 1. Uribarri J
    2. Woodruff S
    3. Goodman S
    4. Cai W
    5. Chen X
    6. Pyzik R
    7. Yong A
    8. Striker GE
    9. Vlassara H

    (2010) Advanced glycation end products in foods and a practical guide to their reduction in the diet

    Journal of the American Dietetic Association 110:911–916.

    https://doi.org/10.1016/j.jada.2010.03.018

    • PubMed
    • Google Scholar
62. 1. Uribarri J
    2. Cai W
    3. Woodward M
    4. Tripp E
    5. Goldberg L
    6. Pyzik R
    7. Yee K
    8. Tansman L
    9. Chen X
    10. Mani V
    11. Fayad ZA
    12. Vlassara H

    (2015) Elevated serum advanced glycation endproducts in obese indicate risk for the metabolic syndrome: a link between healthy and unhealthy obesity?

    The Journal of Clinical Endocrinology and Metabolism 100:1957–1966.

    https://doi.org/10.1210/jc.2014-3925

    • PubMed
    • Google Scholar
63. 1. Vicente Miranda H
    2. Szego ÉM
    3. Oliveira LMA
    4. Breda C
    5. Darendelioglu E
    6. de Oliveira RM
    7. Ferreira DG
    8. Gomes MA
    9. Rott R
    10. Oliveira M
    11. Munari F
    12. Enguita FJ
    13. Simões T
    14. Rodrigues EF
    15. Heinrich M
    16. Martins IC
    17. Zamolo I
    18. Riess O
    19. Cordeiro C
    20. Ponces-Freire A
    21. Lashuel HA
    22. Santos NC
    23. Lopes LV
    24. Xiang W
    25. Jovin TM
    26. Penque D
    27. Engelender S
    28. Zweckstetter M
    29. Klucken J
    30. Giorgini F
    31. Quintas A
    32. Outeiro TF

    (2017) Glycation potentiates α-synuclein-associated neurodegeneration in synucleinopathies

    Brain 140:1399–1419.

    https://doi.org/10.1093/brain/awx056

    • PubMed
    • Google Scholar
64. 1. Vistoli G
    2. De Maddis D
    3. Cipak A
    4. Zarkovic N
    5. Carini M
    6. Aldini G

    (2013) Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): an overview of their mechanisms of formation

    Free Radical Research 47 Suppl 1:3–27.

    https://doi.org/10.3109/10715762.2013.815348

    • PubMed
    • Google Scholar
65. 1. Wolin KY
    2. Carson K
    3. Colditz GA

    (2010) Obesity and cancer

    The Oncologist 15:556–565.

    https://doi.org/10.1634/theoncologist.2009-0285

    • PubMed
    • Google Scholar
66. 1. Wu Z
    2. Isik M
    3. Moroz N
    4. Steinbaugh MJ
    5. Zhang P
    6. Blackwell TK

    (2019) Dietary restriction extends lifespan through metabolic regulation of innate immunity

    Cell Metabolism 29:1192–1205.

    https://doi.org/10.1016/j.cmet.2019.02.013

    • PubMed
    • Google Scholar
67. 1. Zhang Q
    2. Wang Y
    3. Fu L

    (2020) Dietary advanced glycation end-products: Perspectives linking food processing with health implications

    Comprehensive Reviews in Food Science and Food Safety 19:2559–2587.

    https://doi.org/10.1111/1541-4337.12593

    • PubMed
    • Google Scholar

Decision letter after peer review:

Thank you for submitting your article "Methylglyoxal-derived hydroimidazolone, MG-H1, increases food intake by altering tyramine signaling via the GATA transcription factor ELT-3 in Caenorhabditis elegans" for consideration by eLife. Your article has been reviewed by 3 peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Jessica Tyler as the Senior Editor. The reviewers have opted to remain anonymous.

The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.

Essential revisions:

1) As you will see from the reviews attached below, all reviewers found this manuscript interesting and were enthusiastic about the central idea of the work. However, all three reviewers also agreed that there were mechanistic deficiencies in the manuscript that make it unsuitable for publication in eLife without additional data. In particular the reviewers agreed that mechanistic data about how MGH1 acts on the tyraminergic pathway to potentiate food intake were lacking in several places and weak in others (e.g., the elt-3 and tdc-1 data), and require strengthening to better support the proposed model. Specific rescues (elt-3 and tdc-1), functional experiments, and manipulation of tyramine-producing cell activity are all important approaches to obtain mechanistic information that will help identify how some of these players interact with each other (e.g., the cells and circuits that govern the processes).

2) Additional experiments, such as bacterial clearance (reviewer 1, comment 4), and something to rectify reviewer 3, comment 2, should also be completed.

3) Additionally, please note that both reviewer 1 and reviewer 3 point out several instances in the writing and/or figures that require clarification/revision, although these revisions may or may not require data depending on the response (e.g., pumping controls, backcrossing of worms). All reviewer comments are included below for individual responses.

Reviewer #1 (Recommendations for the authors):

These are the points that I feel need to be addressed:

1) The authors claim that MGH-1 modulates (positively) the tyraminergic signal through the activation of the TF elt-3. This is based on the fact that mutations in both tdc-1 and elt-3 suppress the exacerbated pharyngeal pumping of glod-4 mutants (Figure 2E and 3D), that elt-3 expression is increased in MGH1-treated worms (Figure 3F) and that in elt-3-deficient mutants tdc-1 expression is low (Figure 3 E).

First, only two determinations are shown in Figure 3 E (where the mRNA of various elt-3 targets is measured). I think it is too premature to draw conclusions with n=2. It is important to increase the n, especially considering that this is a relevant figure for the whole conclusion of the paper.

Assuming that the conclusions obtained in Figure 1 E are valid, the reasoning that MGH-1 induces the tyraminergic signal through the activation of the TF elt-3 sounds logical. However, this hypothesis does not agree with other data. For instance, MGH-1 treatment does not significantly modulate tdc-1 expression (Figure 1 F). Ser-2 expression is induced upon MGH-1 treatment (Figure 1F) but does not respond to elt-3 (Figure 1E). This raises questions as to how all these players interrelate to modulate the increase in feeding due to AGEs.

It may be possible that the increase in elt-3 upon MGH1 treatment is not sufficient to positively modulate tdc-1 Expression? In this context, one can think that a basal level of elt-3 is needed because otherwise, tyramine release would be low (and this explains the glod-4, tdc-1 and glod-4; elt-3 phenotypes?).

tdc-1 rescue assays with promoters lacking the elt-3 TF binding sequence could demonstrate how important the modulation of tdc-1 expression by elt-3 is during MGH-1 accumulation.

2) Results page 6 (line 117): As exogenous serotonin increases bacterial clearance in glod-4 animals, the authors claim that the increase in pharyngeal pumping in these animals is independent of serotonin. This is not concluded from this experiment. It may in fact be the case that even though it depends on endogenous serotonin release, the exogenous addition of serotonin at a high concentration may further induce pharyngeal pumping. The experiment in the manuscript that actually shows that the induction of pharyngeal pumping by MGH-1 does not depend on serotonin is shown in Figure suppl. 2 A, where MGH-1 treatment induces pumping even in tph-1 worms. To assume that the increase in pumping in glod-4 is independent of 5ht, one would have to compare the pharyngeal pumping (and bacterial clearance) of tph-1 and glod-4;tph-1 worms.

3) Results Page 7 "In addition, we also demonstrated that MG-H1 regulates pharyngeal pumping rate in a dose-dependent manner (Figure 1E)". To assert this, one would have to compare the pharyngeal pumping between the MGH-1 conditions themselves, rather than doing a student test against the naive condition. In addition, it would be advisable to do the experiments on the same day (given the variation in pharyngeal pumping in the naive condition. For example, the first naive shows a lot of dispersion and the third naive condition seems to have a lower average than the first one).

4) Results Page 7 (line 130). "In addition to food consumption, glod-4 mutant exhibited a significantly increased preference towards food source OP50-1 at day 1 and day 3 of adulthood compared to wild-type N2 worms (Figure 1F + Figure Suppl. 1F). Furthermore, we noticed that wild-type N2 worms preferred exogenous MG-H1 compared to MGO when provided with bacterial food source E. coli OP50-1. We did not observe this phenotype in the glod-4 mutant background (Figure 1G), suggesting that MG-H1 and glod-4 null mutation increases feeding by overlapping mechanism."

While the food race experiments may be interesting, the connection with increased food intake is, at the very least, very indirect. The experiment that would actually demonstrate that MGH1 and glod-4 null mutation increases feeding by overlapping mechanism would be the bacterial clearance assay shown in Figure 1D, where the addition of MGH1 does not increase bacterial clearance in a glod-4 mutant background. Something similar could be done with pharyngeal pumping, to confirm the overlapping mechanisms.

With respect to figure 1G, what would be the value corresponding to the attraction to MGO? It is not indicated on the axis.

Beyond that, these food race experiments should not be included in the context of enhanced feeding rate.

5) There is a very large variation in wild-type pharyngeal pumping between experiments. For example, in some experiments it is as high as (160 pp/30sec. Figure 3c) and in others it can be as low as (110 pp/30sec. Figure 2Suppl.) While I understand that for the supplementary figures the authors performed a quick count the difference is still large. Even within the main figures there is a high variation in the controls (see, for example, Figures 2 E, F and G). While I understand that experiments such as pharyngeal pumping can be variable between experiments, I am particularly struck by such variation. Are all the experiments done with animals of the same age and raised under exactly the same conditions?

6) It is not clear, and the authors do not present any model of the mechanism by which MGH1 excess modulates the tyraminergic signal to increase food intake. It is only shown that elt-3 may be important and that tdc-1, ser-2 and tyra-2 appear to be relevant. There are no rescue or functional experiments showing where these players would be playing their role.

For example, would tyramine release be affected at the level of RIM, RIC or UV cells? Perhaps it would be good to specifically silence these neurons (e.g. with the expression of histamine-triggered anion channels, see Pokala et al., PNAS, 2014 or De Rosa et al., Nature, 2019) and see if MGH-1 is able to induce pharyngeal pumping.

It is also unclear where elt-3 is relevant. It would be important to express this TF specifically in tdc-1 expressing cells and analyze whether the response is similar to wild-type.

This is one of my main concerns regarding the manuscript. The lack of mechanistic details to understand how AGEs accumulation increases food intake argues against the significance of the work.

7) Exogenous TA has been shown to reduce pharyngeal pumping (Greer et al., 2008). Furthermore, the absence of SER-2 suppresses the tyraminergic inhibition of exacerbated pharyngeal pumping in serotonin-treated worms (Rex et a, 2004. https://doi.org/10.1111/j.1471-4159.2004.02787.x).

Since the authors' results point more towards a positive modulation of pharyngeal pumping by tyramine and ser-2 , it would be important to discuss this paradox further.

8) Many of the strains listed have not been backcrossed to clean up the background. For example: RB1690 ser-2(ok2103); VC343 glod-4(gk189); VC125 tyra-3(ok325); RB745 ser-4(ok512), etc. For tyra-2 it is not indicated which strain is used.

If backcrosses have not been performed, it is essential to perform the experiments with the clean strains. If they have done them, the strain they used for the experiments is not called as they named it. Please clarify this.

At the same time, it would be advisable that in the absence of rescue experiments, they use other alleles to confirm the observed phenotypes.

Reviewer #2 (Recommendations for the authors):

The study is generally well done, but the strains don't appear to be outcrossed, and none of the effects are rescued. At least for the main results, tdc-1 and elt-3, there are multiple mutants available at CGC. The authors should rescue the original mutant or show the same results using a different allele. It would also be helpful for the reader to show the alleles in the figure legend.

Reviewer #3 (Recommendations for the authors):

There are several points that need to be substantially improved.

1. The writing of the manuscript needs to be improved substantially. The introduction is very confusing with too many abbreviations. I would suggest a diagram to show the reaction of α-dicarbonyl (α-DG), AGEs, glyoxalases. In each of these terms, you can list the examples in that category, for example: α-DG (MGO, GO, 3DG etc.), AGEs (MG-H1, CEL, CML, GOLD, MOLD), glyoxalases (glod-4, glod-1, etc.). The introduction is not organized with a focus in each paragraph. Transitions between sentences need to be improved substantially too.

2. It is not explained or addressed in the manuscript why glod-4 KO in which we would expect less MG-H1, and MG-H1 supplementation both increase pumping. It will be helpful to measure MG-H1 level in glod-4 KO. This will also help to understand the result that the pumping rate increases are MG-H1 dose-dependent, however, glod-4 KO and MG-H1 supplementation is not additive in the increase of pumping.

3. Figure 2B shows all 66 genes are upregulated in glod-4 compared to WT. A concern is whether the gene expression is properly normalized. Are there downregulated genes other than the 66 genes? How many genes are up- and down- regulated in glod-4 vs. WT. All these necessary descriptions are not mentioned in the results part. The labeling of both A and B panels are too small for recognizing the gene and pathway names. Among the 66 "neurotransmitters and feeding genes", how many of them are neurotransmitter genes and how were they defined? Are tph-1, tdc-1, tbh-1, cat-2 genes in this list? Similar question, how were the "feeding genes" defined?

4. Figure 2B used glod-4 RNAi while other results pumping data were collected on glod-4KO. Why glod-4 KO was not used in transcriptomics data. And please label on panel B indicating glod-4 RNAi. And it is described in the method part that RNA-seq was done on "N2 and mutant animals" but not RNAi.

5. tdc-1 and the two tyramine receptors knockouts abrogate pumping rate by MG-H1 and glod-4. This would indicate that tyramine release is necessary for the pumping rate increase by MG-H1 and glod-4. Did the author try rescue the abrogation by tyramine supplementation? This is a valid control to strengthen the hypothesis.

6. The authors previously showed that glod-4 KO shortens lifespan, and supplementation of glod-4 substrates MGO also shortens lifespan. The results in Figure 4 of lifespan rescue by tdc-1 is not sufficient to support that increased feeding shortens glod-4 KO lifespan suggested in the manuscript. The valid conclusion from this data is that the lifespan decreases by glod-4 KO requires tyramine synthesis and probably tyramine signaling since the two receptors are also required for the shorter lifespan. Does MG-H1 addition rescue or further shorten glod-4 KO lifespan since MG-H1 also increases pumping rate not additively to glod-4 KO? Figure 4D labeling is too small.

Essential revisions:

1) As you will see from the reviews attached below, all reviewers found this manuscript interesting and were enthusiastic about the central idea of the work. However, all three reviewers also agreed that there were mechanistic deficiencies in the manuscript that make it unsuitable for publication in eLife without additional data. In particular the reviewers agreed that mechanistic data about how MGH1 acts on the tyraminergic pathway to potentiate food intake were lacking in several places and weak in others (e.g., the elt-3 and tdc-1 data), and require strengthening to better support the proposed model. Specific rescues (elt-3 and tdc-1), functional experiments, and manipulation of tyramine-producing cell activity are all important approaches to obtain mechanistic information that will help identify how some of these players interact with each other (e.g., the cells and circuits that govern the processes).

We thank the editors and reviewers for their time in reviewing our manuscript. We also appreciate the strengths pointed out by the reviewers and their constructive feedback. We address these concerns below.

To strongly demonstrate the necessity of tyramine signaling in glod-4 mutants to increase pharyngeal pumping, we supplemented tyramine exogenously (instead of laser ablation/manipulation of tyramine-producing cells) to either elt-3;glod-4 or tdc-1;glod-4 double mutants and analyzed the pumping behavior. Further, we chose to supplement tyramine as a rescue strategy in the mutants that lack tyramine signaling. Our new results in Figure B+C demonstrate that exogenous tyramine treatment of double mutants increased their pumping levels to glod-4 single mutant worms. Thus, supporting the hypothesis that lack of elt-3 reduces tyramine signaling (note the reduced expression of tdc-1 in elt-3 mutants, Figure 4E) to suppress the pumping in elt-3;glod-4 double mutants. This data also demonstrates the importance of elt-3 in mediating increased pumping in glod-4 mutants via tyramine. Similarly, exogenous tyramine supplementation in tdc-1;glod-4 double mutant also increased pharyngeal pumping to glod-4 single mutant levels. However, the pumping is not increased in double mutants such as ser-2;glod-4, and tyra-2;glod-4 which lacks tyramine receptors (Figure D+E).

Further, we have shown in Figure 4F that MG-H1 treatment of N2 wildtype worms modulates the expression levels of the gene in the tyramine signaling pathway, i.e., increases the expression of elt-3 as well as ser-2 which are essential for increased feeding in glod-4 mutants (Figure 3+4). Thus, either exogenous treatment of MG-H1 or glod-4 mutants (with increased accumulation of MG-H1, Figure2—figure supplement 1H+1I) increased tyramine signaling by modulating genes in the tyramine pathway. The mechanism is explained in the discussion of the revised manuscript on pages 21 and 22.

However, treatment of N2 wildtype worms with tyramine resulted in a significant decrease in the pharyngeal pumping (Figure 5A). Also, tyramine is shown to suppress pharyngeal pumping in N2 wildtype worms (1). These findings demonstrate that tyramine increases pharyngeal pumping only in the glod-4 mutant background but decreases pumping in the N2 wildtype background. The mechanism behind this behavioral switch upon activation of the tyramine signaling pathway (i.e., from a suppressor of pharyngeal pumping in wildtype into a stimulator in glod-4 mutant background) remains elusive. Although tdc-1 is expressed only in RIC, RIM, UV2 cells and gonadal sheath cells, tyramine receptors are located at distinct tissues (1) (2); thus, it can be speculated that AGEs, especially MG-H1, can modify the tissue-specific expression of tyramine receptors resulting in observed behavioral switch in response to tyramine signaling. This hypothesis can only be addressed by methodologies such as single-cell RNA sequencing which is beyond the scope of the current study.

2) Additional experiments, such as bacterial clearance (reviewer 1, comment 4), and something to rectify reviewer 3, comment 2, should also be completed.

We have addressed reviewer 1-comment 4 and reviewer 3-comment 2 with appropriate experiments and explanation, please refer below.

3) Additionally, please note that both reviewer 1 and reviewer 3 point out several instances in the writing and/or figures that require clarification/revision, although these revisions may or may not require data depending on the response (e.g., pumping controls, backcrossing of worms). All reviewer comments are included below for individual responses.

All the comments that do not require additional experiments but require appropriate explanation are revised as suggested by the reviewers in the new revised manuscript. Please see the rebuttal below.

Reviewer #1 (Recommendations for the authors):

These are the points that I feel need to be addressed:

1) The authors claim that MGH-1 modulates (positively) the tyraminergic signal through the activation of the TF elt-3. This is based on the fact that mutations in both tdc-1 and elt-3 suppress the exacerbated pharyngeal pumping of glod-4 mutants (Figure 2E and 3D), that elt-3 expression is increased in MGH1-treated worms (Figure 3F) and that in elt-3-deficient mutants tdc-1 expression is low (Figure 3 E).

First, only two determinations are shown in Figure 3 E (where the mRNA of various elt-3 targets is measured). I think it is too premature to draw conclusions with n=2. It is important to increase the n, especially considering that this is a relevant figure for the whole conclusion of the paper.

As recommended by the reviewer, we have now increased the sample size to 5 biological replicates (Figure 4E). Our data shows that tdc-1 expression levels are significantly reduced in elt-3 mutant worms. Further, we now have data demonstrating that exogenous tyramine treatment on elt-3;glod-4 double mutant increased the pharyngeal pumping similar to glod-4 single mutant worms (Figure 5B) indicating that elt-3 is necessary for tyramine signaling.

However, it can be observed that ser-2 expression significantly increased in elt-3 mutant worms which can be inferred as a compensatory mechanism for lack of tyramine signaling by increasing the expression of tyramine receptor.

Assuming that the conclusions obtained in Figure 1 E are valid, the reasoning that MGH-1 induces the tyraminergic signal through the activation of the TF elt-3 sounds logical. However, this hypothesis does not agree with other data. For instance, MGH-1 treatment does not significantly modulate tdc-1 expression (Figure 1 F). Ser-2 expression is induced upon MGH-1 treatment (Figure 1F) but does not respond to elt-3 (Figure 1E). This raises questions as to how all these players interrelate to modulate the increase in feeding due to AGEs.

It may be possible that the increase in elt-3 upon MGH1 treatment is not sufficient to positively modulate tdc-1 Expression?. In this context, one can think that a basal level of elt-3 is needed because otherwise, tyramine release would be low (and this explains the glod-4, tdc-1 and glod-4; elt-3 phenotypes?).

tdc-1 rescue assays with promoters lacking the elt-3 TF binding sequence could demonstrate how important the modulation of tdc-1 expression by elt-3 is during MGH-1 accumulation.

We show that MG-H1 treatment modulates factors in the elt-3-tdc-1/tyramine pathways (Figure 4F, especially increased expression of elt-3 and ser-2 genes) to increase pharyngeal pumping. In order to strengthen the involvement of tyramine signaling, we supplemented tyramine (tyramine rescue) to either elt-3;glod-4, or tdc-1;glod-4 double mutant instead of tdc-1 rescue suggested by the reviewer. Our results in Figure B+C demonstrate that exogenous tyramine treatment of double mutants increased the pumping levels to glod-4 single mutant worms. Thus, we can understand that lack of elt-3 modulates tyramine levels to suppress the pumping in elt-3;glod-4 double mutants. Similarly, exogenous tyramine supplementation in tdc-1;glod-4 double mutant also increased pharyngeal pumping to glod-4 single mutant levels. However, the pumping is not increased in double mutants such as ser-2;glod-4, and tyra-2;glod-4 which lack tyramine receptors.

Further, from the literature we can find that tyramine suppresses the pharyngeal pumping in C. elegans (1). Thus, treatment of N2 wildtype worms with tyramine resulted in a significant decrease in the pharyngeal pumping (Figure 5A). These findings demonstrate that tyramine increases pharyngeal pumping only in glod-4 mutant background but decreases pumping in N2 wildtype background. And further analysis is required to understand the mechanistic shift in the tyramine signaling, however it is beyond the scope of this research article.

2) Results page 6 (line 117): As exogenous serotonin increases bacterial clearance in glod-4 animals, the authors claim that the increase in pharyngeal pumping in these animals is independent of serotonin. This is not concluded from this experiment. It may in fact be the case that even though it depends on endogenous serotonin release, the exogenous addition of serotonin at a high concentration may further induce pharyngeal pumping. The experiment in the manuscript that actually shows that the induction of pharyngeal pumping by MGH-1 does not depend on serotonin is shown in Figure suppl. 2 A, where MGH-1 treatment induces pumping even in tph-1 worms. To assume that the increase in pumping in glod-4 is independent of 5ht, one would have to compare the pharyngeal pumping (and bacterial clearance) of tph-1 and glod-4;tph-1 worms.

As recommended by the reviewer, we compared the pharyngeal pumping in tph-1 (mg280) and tph-1;glod-4 mutants background (Figure 2—figure supplement 1D). Worms lacking tph-1 (tryptophan hydroxylase) enzyme, as well as tph-1;glod-4 double mutants, which lack serotonin (1) (3) show decreased pumping compared to N2 wildtype worms; however, tph-1;glod-4 double mutant worms show significantly increased pumping compared to tph-1 single mutants demonstrating that glod-4 mutation dependent increase in pharyngeal pumping is independent of serotonin. Also, note that MG-H1 treatment significantly increased pharyngeal pumping in tph-1 mutants in Figure 3—figure supplement 2A which supports our claim that glod-4 mutant induced pumping is independent of serotonin.

3) Results Page 7 "In addition, we also demonstrated that MG-H1 regulates pharyngeal pumping rate in a dose-dependent manner (Figure 1E)". To assert this, one would have to compare the pharyngeal pumping between the MGH-1 conditions themselves, rather than doing a student test against the naive condition. In addition, it would be advisable to do the experiments on the same day (given the variation in pharyngeal pumping in the naive condition. For example, the first naive shows a lot of dispersion and the third naive condition seems to have a lower average than the first one).

Our conclusion is based on the stronger significance (lower p value) caused by reduced dispersion of the data at higher concentration of MG-H1. This indicates that higher concentrations of MG-H1 can increase the pharyngeal pumping in almost all the treatment worms thus predisposing the worms with lower pumping rates in the Gaussian distribution to higher pumping levels. Now, it is made clear in the manuscript on page 18.

It is important to explain that there were a few technical difficulties in recording pumping videos from several treatment groups in a narrow window of time. From Figure 2A it is very evident that pharyngeal pumping is very dynamic which changes with the worm’s development. Further, it takes about a minute to record a 40 sec pumping video which includes finding a worm and focusing to start the recording. Approximately 26 to 30 worms were recorded per treatment group which requires 1 hour (including personal fatigue experienced by the recorder). Dynamic pumping behavior can induce variations between the worms recorded in the first treatment group and the last treatment group especially when there are 5 treatment groups to record pumping videos which takes around 5 hours. Thus, we decided to record the minimum required treatment groups as possible to reduce variations caused by delayed time and worms’ development. In case, when more treatment/genetic groups need to be compared the video recording between different groups are staggered (recording of 10 worms per group followed by recording worms from other groups and repeating this cycle until 30 worms per group were recorded) to minimize the various caused.

Further, variations are also induced by fluctuations in the lab temperature, which is overcome by preparing 3 plates of worms for a single treatment group and only 10 worms are recorded per plate while the other plates are incubated at 20 ̊C.

An insight into the above-mentioned strategies has been updated on the “Materials and methods” section on page 25.

4) Results Page 7 (line 130). "In addition to food consumption, glod-4 mutant exhibited a significantly increased preference towards food source OP50-1 at day 1 and day 3 of adulthood compared to wild-type N2 worms (Figure 1F + Figure Suppl. 1F). Furthermore, we noticed that wild-type N2 worms preferred exogenous MG-H1 compared to MGO when provided with bacterial food source E. coli OP50-1. We did not observe this phenotype in the glod-4 mutant background (Figure 1G), suggesting that MG-H1 and glod-4 null mutation increases feeding by overlapping mechanism."

While the food race experiments may be interesting, the connection with increased food intake is, at the very least, very indirect. The experiment that would actually demonstrate that MGH1 and glod-4 null mutation increases feeding by overlapping mechanism would be the bacterial clearance assay shown in Figure 1D, where the addition of MGH1 does not increase bacterial clearance in a glod-4 mutant background. Something similar could be done with pharyngeal pumping, to confirm the overlapping mechanisms.

With respect to figure 1G, what would be the value corresponding to the attraction to MGO? It is not indicated on the axis.

Beyond that, these food race experiments should not be included in the context of enhanced feeding rate.

As recommended by the reviewer, we performed pharyngeal pumping quantification on glod-4 mutant worms treated with 150 µM MG-H1 and compared with N2 and glod-4 either treated with arginine or MG-H1 (Author response image 1). Our data demonstrates that glod-4 ARG does not differ significantly with glod-4 MG-H1 suggesting both glod-4 mutants and MG-H1 treatment modulates similar pathway to increase feeding. From Figure 4F, it is also evident that MG-H1 treatment induces gene expression changes in elt-3-tyramine signaling pathways which also validates that MG-H1 acts through elt-3-tyramine signaling pathway.

Author response image 1

Download asset Open asset

We thank the reviewer for pointing out the lack of description in old Figure 1G. We apologize that a small proofreading error resulted in a wrong graph which is updated now with two graphs as shown in Figure 2G and 2H. Figure 2G is a comparison between N2 wildtype worm treated with either MGO or MG-H1 with untreated control, showing that mixing of MGO to OP50-1 did not significantly increase the attraction of worms towards food, unlike MG-H1. Figure 2H demonstrates that glod-4 mutant’s attraction towards food is unaffected by MG-H1 when mixed with OP50-1.

5) There is a very large variation in wild-type pharyngeal pumping between experiments. For example, in some experiments it is as high as (160 pp/30sec. Figure 3c) and in others it can be as low as (110 pp/30sec. Figure 2Suppl.) While I understand that for the supplementary figures the authors performed a quick count the difference is still large. Even within the main figures there is a high variation in the controls (see, for example, Figures 2 E, F and G). While I understand that experiments such as pharyngeal pumping can be variable between experiments, I am particularly struck by such variation. Are all the experiments done with animals of the same age and raised under exactly the same conditions?

Yes, the worms were grown in the same conditions and the videos were recorded at similar ages, ± few minutes difference, throughout the project. As pointed out by the reviewer pharyngeal pumping is variable and dynamic. Thus, we realized the importance of validating our findings with alternative methodologies, for example – very important pumping data was supported by food clearance assay (Figure 2B+2D in the manuscript). Further, a few important pharyngeal pumping counts were performed double-blinded to minimize the bias.

It is important to explain that there were a few technical difficulties in recording pumping videos from several treatment groups in a narrow window of time. From Figure 2A it is very evident that pharyngeal pumping is very dynamic which changes with the worm’s development. Further, it takes about a minute to record a 40 sec pumping video which includes finding a worm and focusing to start the recording. Approximately 26 to 30 worms were recorded per treatment group per biological replicate which requires 1 hour (including personal fatigue experienced by the recorder). Dynamic pumping behavior can induce variations between the worms recorded in the first treatment group and the last treatment group especially when there are 5 treatment groups to record pumping videos which takes around 5 hours. Thus, we decided to record the minimum required treatment groups as possible to reduce variations caused by delayed time and worms’ development. In case, when more treatment/genetic groups need to be compared the video recordings between different groups are staggered (recording of 10 worms per group followed by recording worms from other groups and repeating this cycle until 30 worms per group were recorded) to minimize the variations.

Further, variations are also induced by fluctuations in the lab temperature, which is overcome by preparing 3 plates of worms for a single treatment group and only 10 worms are recorded per plate while the other plates are incubated at 20 ̊C.

To further average out the variations, the biological repeats were pooled together to represent the final data which is already explained in the “Materials and methods” section on Page 25.

Also, some odd-behaving worms were not recorded such as worms that are stationary for prolonged amounts of time, worms that did not show any pharyngeal pumping, and worms that are potentially injured with any visible damages, etc.

An insight on the above-mentioned strategies has been updated on the “Materials and methods” section on page 25.

6) It is not clear, and the authors do not present any model of the mechanism by which MGH1 excess modulates the tyraminergic signal to increase food intake. It is only shown that elt-3 may be important and that tdc-1, ser-2 and tyra-2 appear to be relevant. There are no rescue or functional experiments showing where these players would be playing their role.

For example, would tyramine release be affected at the level of RIM, RIC or UV cells? Perhaps it would be good to specifically silence these neurons (e.g. with the expression of histamine-triggered anion channels, see Pokala et al., PNAS, 2014 or De Rosa et al., Nature, 2019) and see if MGH-1 is able to induce pharyngeal pumping.

It is also unclear where elt-3 is relevant. It would be important to express this TF specifically in tdc-1 expressing cells and analyze whether the response is similar to wild-type.

This is one of my main concerns regarding the manuscript. The lack of mechanistic details to understand how AGEs accumulation increases food intake argues against the significance of the work.

To further demonstrate the role of tyramine signaling in mediating MG-H1-induced increased pharyngeal pumping, as well as in glod-4 mutants, we supplemented tyramine to either elt-3;glod-4 or tdc-1;glod-4 double mutant and analyzed the pumping behavior. Our results in Figure 5B-E demonstrate that exogenous tyramine treatment of double mutants increased the pumping levels to glod-4 single mutant worms. Thus, we show that lack of elt-3 modulates tyramine signaling to suppress the pumping in elt-3;glod-4 double mutants. This demonstrates the importance of elt-3 in mediating increased pumping in glod-4 mutants via tyramine. Similarly, exogenous tyramine supplementation in tdc-1;glod-4 double mutant also increased pharyngeal pumping to glod-4 single mutant levels. However, the pumping is not increased in double mutants such as ser-2;glod-4, and tyra-2;glod-4 which lacks tyramine receptors.

Silencing the tyramine synthesis neurons to dissect the neuronal circuitry is an interesting experiment, as suggested by the reviewers; however, it is very time-consuming and beyond the scope of this study. We have demonstrated that lack of either tyramine or tyramine receptor suppressed the pumping in the glod-4 mutant background which was rescued by exogenous tyramine in elt-3;glod-4 and tdc-1;glod-4 double mutant.

7) Exogenous TA has been shown to reduce pharyngeal pumping (Greer et al., 2008). Furthermore, the absence of SER-2 suppresses the tyraminergic inhibition of exacerbated pharyngeal pumping in serotonin-treated worms (Rex et a, 2004. https://doi.org/10.1111/j.1471-4159.2004.02787.x).

Since the authors' results point more towards a positive modulation of pharyngeal pumping by tyramine and ser-2 , it would be important to discuss this paradox further.

Treatment of N2 wildtype worms with tyramine resulted in a significant decrease in the pharyngeal pumping (Figure 5). Tyramine suppressing pharyngeal pumping has already been described in the literature (1), as well as indicated by the reviewer. However, our data from elt-3;glod-4 and tdc-1;glod-4 double mutants show that tyramine treatment increased the pumping to glod-4 single mutant levels (Figure B+C). Also, double mutants lacking tyramine receptors were not rescued by tyramine (Figure D+E). These findings demonstrate that tyramine increases pharyngeal pumping only in glod-4 mutant background but decreases pumping in N2 wildtype background.

The mechanism behind this behavioral switch upon activation of the tyramine signaling pathway (i.e., from a suppressor of pharyngeal pumping in wildtype into a stimulator in glod-4 mutant background) remains elusive. Although tdc-1 is expressed only in RIC, RIM, UV2 pair of cells and gonadal sheath cells, tyramine receptors are located at distinct tissues (1) (2); thus, it can be speculated that AGEs, especially MG-H1, can modify the tissue-specific expression of tyramine receptors resulting in observed behavioral switch in response to tyramine signaling. This hypothesis can only be addressed by methodologies such as single-cell RNA sequencing which is beyond the scope of the current study. Currenty, we discussed this paradox in the ‘Discussion’ section on pages 21 and 22.

8) Many of the strains listed have not been backcrossed to clean up the background. For example: RB1690 ser-2(ok2103); VC343 glod-4(gk189); VC125 tyra-3(ok325); RB745 ser-4(ok512), etc. For tyra-2 it is not indicated which strain is used.

If backcrosses have not been performed, it is essential to perform the experiments with the clean strains. If they have done them, the strain they used for the experiments is not called as they named it. Please clarify this.

At the same time, it would be advisable that in the absence of rescue experiments, they use other alleles to confirm the observed phenotypes.

1. All the strains are outcrossed at least 3 times or more with N2 wildtype strain obtained from CGC, we have updated the “Materials and methods” now.

2. The strain used for tyra-2 is now mentioned in the “Materials and methods” as FX1846 tyra-2 (tm1846).

3. As recommended by the reviewer, we have used another allelic mutant of tdc-1 (n3420) and evaluated its pumping in n3420 as well as in tdc-1(n3420);glod-4 double mutant (Author response image 2). Our results demonstrate that glod-4 single mutant shows significantly increased pumping compared to N2 wildtype worms; however, tdc-1 (n3420);glod-4 (gk189) double mutant worms do not show any significant difference indicating tdc-1 enzyme is essential for increased feeding in glod-4 single mutants.

4. Similarly, we also evaluated the role of elt-3 in mediating the pharyngeal pumping in glod-4 single mutants by knockdown elt-3 using RNAi (Author response image 2). Again, our results demonstrate that elt-3 is essential for increased feeding in glod-4 single mutants.

Author response image 2

Download asset Open asset

Reviewer #2 (Recommendations for the authors):

The study is generally well done, but the strains don't appear to be outcrossed, and none of the effects are rescued. At least for the main results, tdc-1 and elt-3, there are multiple mutants available at CGC. The authors should rescue the original mutant or show the same results using a different allele. It would also be helpful for the reader to show the alleles in the figure legend.

We thank the reviewer for pointing out the importance of using either multiple allelic mutants or rescue of the mutant phenotype to validate, as well as strengthen, the role of tdc-1 and elt-3 genes in modulating the feeding behavior.

1. The strains used in this study are outcrossed at least 3 times, which is now indicated in the ‘Materials and methods’ section on Page 24.

2. As requested by the reviewer, we now included pharyngeal pumping data from another allelic mutant of MT10661 tdc-1(n3420) to demonstrate that lack of tdc-1 suppresses pharyngeal pumping in glod-4;tdc-1 double mutant. Also, we knocked down the elt-3 in glod-4 mutants worms using RNAi feeding approach and demonstrated that elt-3 is essential of increased feeding in glod-4 mutants (Author response image 2) .

3. Finally, we rescued increased pharyngeal pumping (glyoxalase glod-4 mutant phenotype) in either tdc-1;glod-4 or elt-3;glod-4 double mutants with exogenous administration of tyramine. This result shows that tyramine signaling is essential for increased feeding in glyoxalase glod-4 mutants which is suppressed with the lack of either tdc-1 or elt-3 genes. However, exogenous tyramine did not increase pharyngeal pumping in tyramine receptor-glod-4 double mutants.

Reviewer #3 (Recommendations for the authors):

There are several points that need to be substantially improved.

1. The writing of the manuscript needs to be improved substantially. The introduction is very confusing with too many abbreviations. I would suggest a diagram to show the reaction of α-dicarbonyl (α-DG), AGEs, glyoxalases. In each of these terms, you can list the examples in that category, for example: α-DG (MGO, GO, 3DG etc.), AGEs (MG-H1, CEL, CML, GOLD, MOLD), glyoxalases (glod-4, glod-1, etc.). The introduction is not organized with a focus in each paragraph. Transitions between sentences need to be improved substantially too.

We thank the reviewer for pointing out an unclear Introduction. As per reviewer’s request, we now introduced a pictorial diagram in the Figure 1 to explain the interactions between dicarbonyls, AGEs and glyoxalases enzymes as well as explained it in the pages 3 and 4. Also, a detailed understanding about dicarbonyls, AGEs, glyoxalases, and their impact on the health as well as disease can be obtained from a review from our lab, Chaudhuri et la. 2018 (4).

2. It is not explained or addressed in the manuscript why glod-4 KO in which we would expect less MG-H1, and MG-H1 supplementation both increase pumping. It will be helpful to measure MG-H1 level in glod-4 KO. This will also help to understand the result that the pumping rate increases are MG-H1 dose-dependent, however, glod-4 KO and MG-H1 supplementation is not additive in the increase of pumping.

It has been previously shown that glod-4 KO worms show more MGO (5). We now further clarify that glyoxalase enzymes detoxify dicarbonyls (such as MGO, GO, etc.) and the lack of glyoxalase enzymes results in accumulation of dicarbonyls which interacts with biomolecules to increase the formation and accumulation of AGEs in pages 3 and 4 (Figure 1). Thus, glod-4 glyoxalase mutant worms accumulate more MG-H1 which signals to increase the feeding which is comparable to increased feeding after exogenous treatment of MG-H1. Now, we also quantified the levels of MG-H1 in glod-4 mutant worms using mass spectrometry (LC-MRM) and included the data in Figure 2—figure supplement 1H+1I, which shows significantly increased MG-H1 levels.

3. Figure 2B shows all 66 genes are upregulated in glod-4 compared to WT. A concern is whether the gene expression is properly normalized. Are there downregulated genes other than the 66 genes? How many genes are up- and down- regulated in glod-4 vs. WT. All these necessary descriptions are not mentioned in the results part. The labeling of both A and B panels are too small for recognizing the gene and pathway names. Among the 66 "neurotransmitters and feeding genes", how many of them are neurotransmitter genes and how were they defined? Are tph-1, tdc-1, tbh-1, cat-2 genes in this list? Similar question, how were the "feeding genes" defined?

1. The RNAseq is normalized by FPKM (fragments per kilobase of exon per million fragments mapped) method.

2. The total number of genes identified in the RNAseq analysis is 20,277. The total genes that changed significantly are 5035 with upregulated genes amounting to 2237 and downregulated amounts to 2798 genes. This information is now included on page 10 of the manuscript.

3. Gene ontology was performed in DAVID v6.8 which identified neurotransmitter and feeding genes which is mentioned in the “Materials and methods” section. Because neurotransmitters also regulate feeding behavior, it is essential to understand that a clear separation between neurotransmitter genes and feeding genes is difficult.

4. Gene tph-1 was identified in RNAseq but there was no significant difference between N2 and glod-4 RNAi. However, RNAseq did not identify the following genes tdc-1, tbh-1, and cat-2.

4. Figure 2B used glod-4 RNAi while other results pumping data were collected on glod-4KO. Why glod-4 KO was not used in transcriptomics data. And please label on panel B indicating glod-4 RNAi. And it is described in the method part that RNA-seq was done on "N2 and mutant animals" but not RNAi.

As requested by the reviewer, we labeled the RNAseq heatmap appropriately (Figure 3A). We prepared samples for RNAseq from both glod-4 KO worms and by glod-4 RNAi knockdown. During further processing, samples from glod-4 RNAi worms demonstrated the best quality for RNAseq analysis. However, samples from glod-4 KO required further standardization to pass the quality control. Thus, we utilized samples from glod-4 RNAi instead of samples from glod-4 null mutants for RNAseq analysis.

5. tdc-1 and the two tyramine receptors knockouts abrogate pumping rate by MG-H1 and glod-4. This would indicate that tyramine release is necessary for the pumping rate increase by MG-H1 and glod-4. Did the author try rescue the abrogation by tyramine supplementation? This is a valid control to strengthen the hypothesis.

As recommended by the reviewer, we exogenously supplemented tyramine in different genetic backgrounds and demonstrated its role in modulating pharyngeal pumping. Tyramine supplementation in N2(wt) worms significantly reduced the pumping at various concentrations (Figure 5A). However, tyramine supplementation in double mutants such as elt-3;glod-4 and tdc-1;glod-4 resulted in a significant increase in the pumping comparable to glod-4 single mutants. Further, tyramine supplementation in tyramine receptor mutants leads to no changes in the pumping. This result demonstrates that in wildtype background tyramine suppresses pumping consistent with the existing literature (1); however, in the glod-4 mutant background tyramine increases pumping. Thus far, the mechanisms by which tyramine increased the pumping (signaling switch from a suppressor in wildtype worms into pharyngeal pumping activator in glod-4 mutant background) in glod-4 mutants remains elusive and needs further studies in the future.

6. The authors previously showed that glod-4 KO shortens lifespan, and supplementation of glod-4 substrates MGO also shortens lifespan. The results in Figure 4 of lifespan rescue by tdc-1 is not sufficient to support that increased feeding shortens glod-4 KO lifespan suggested in the manuscript. The valid conclusion from this data is that the lifespan decreases by glod-4 KO requires tyramine synthesis and probably tyramine signaling since the two receptors are also required for the shorter lifespan. Does MG-H1 addition rescue or further shorten glod-4 KO lifespan since MG-H1 also increases pumping rate not additively to glod-4 KO? Figure 4D labeling is too small.

1. We thank the reviewer for suggesting appropriate inference of the data. The conclusion was updated in the manuscript on pages 16 and 17, as suggested by the reviewer. Further, we also performed lifespan assay in N2 and glod-4 mutant worms with 150 µM MG-H1 treatment (Figure 6—figure supplement 1). MG-H1 treatment significantly reduced the lifespan in N2 wildtype worms. Glyoxalase mutant worms showed significantly shorter lifespans than N2 worms; however, MG-H1 treatment did not further affect the lifespan of glod-4 mutant worms.

2. We enlarged figure 6D (old figure 4D).

References:

1. Dallière N, Holden-Dye L, Dillon J, O'Connor V, Walker RJ. Caenorhabditis elegans Feeding Behaviors. Oxford Research Encyclopedia of Neuroscience2017.

2. Rex E, Hapiak V, Hobson R, Smith K, Xiao H, Komuniecki R. TYRA-2 (F01E11.5): a Caenorhabditis elegans tyramine receptor expressed in the MC and NSM pharyngeal neurons. J Neurochem. 2005;94(1):181-91.

3. Ji Ying Sze MV, Curtis Loer, Yang Shi & Gary Ruvkun. Food and metabolic signalling defects in a Caenorhabditis elegans serotonin-synthesis mutant. Nature. 2000;403:560-4.

4. Chaudhuri J, Bains Y, Guha S, Kahn A, Hall D, Bose N, et al. The Role of Advanced Glycation End Products in Aging and Metabolic Diseases: Bridging Association and Causality. Cell Metab. 2018;28(3):337-52.

5. Chaudhuri J, Bose N, Gong J, Hall D, Rifkind A, Bhaumik D, et al. A Caenorhabditis elegans Model Elucidates a Conserved Role for TRPA1-Nrf Signaling in Reactive α-Dicarbonyl Detoxification. Curr Biol. 2016;26(22):3014-25.

Author details

1. Muniesh Muthaiyan Shanmugam

   The Buck Institute for Research on Aging, Novato, United States

   Contribution

   Conceptualization, Data curation, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing – original draft, Writing – review and editing

   Competing interests

   No competing interests declared

   "This ORCID iD identifies the author of this article:" 0000-0001-8018-2032

2. Jyotiska Chaudhuri

   The Buck Institute for Research on Aging, Novato, United States

   Contribution

   Conceptualization, Data curation, Formal analysis, Methodology, Writing – original draft

   Competing interests

   No competing interests declared

3. Durai Sellegounder

   The Buck Institute for Research on Aging, Novato, United States

   Contribution

   Conceptualization, Data curation, Formal analysis, Writing – review and editing

   Competing interests

   No competing interests declared

   "This ORCID iD identifies the author of this article:" 0000-0002-0776-0307

4. Amit Kumar Sahu

   The Buck Institute for Research on Aging, Novato, United States

   Contribution

   Data curation, Formal analysis, Writing – review and editing

   Competing interests

   No competing interests declared

   "This ORCID iD identifies the author of this article:" 0000-0003-0063-5447

5. Sanjib Guha

   The Buck Institute for Research on Aging, Novato, United States

   Contribution

   Conceptualization, Data curation, Formal analysis, Writing – original draft

   Competing interests

   No competing interests declared

6. Manish Chamoli

   The Buck Institute for Research on Aging, Novato, United States

   Contribution

   Data curation, Formal analysis, Writing – review and editing

   Competing interests

   No competing interests declared

   "This ORCID iD identifies the author of this article:" 0000-0003-0339-7894

7. Brian Hodge

   The Buck Institute for Research on Aging, Novato, United States

   Contribution

   Formal analysis

   Competing interests

   No competing interests declared

8. Neelanjan Bose

   The Buck Institute for Research on Aging, Novato, United States

   Contribution

   Data curation, Formal analysis, Methodology

   Competing interests

   No competing interests declared

9. Charis Roberts

   Department of Chemistry, University of California, Berkeley, Berkeley, United States

   Contribution

   Formal analysis, Methodology

   Competing interests

   No competing interests declared

10. Dominique O Farrera

    Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, United States

    Contribution

    Data curation, Formal analysis

    Competing interests

    No competing interests declared

11. Gordon Lithgow

    The Buck Institute for Research on Aging, Novato, United States

    Contribution

    Supervision, Funding acquisition

    Competing interests

    No competing interests declared

    "This ORCID iD identifies the author of this article:" 0000-0002-8953-3043

12. Richmond Sarpong

    Department of Chemistry, University of California, Berkeley, Berkeley, United States

    Contribution

    Formal analysis, Methodology

    Competing interests

    No competing interests declared

13. James J Galligan

    Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, United States

    Contribution

    Data curation, Formal analysis

    Competing interests

    No competing interests declared

    "This ORCID iD identifies the author of this article:" 0000-0002-5612-0680

14. Pankaj Kapahi

    1. The Buck Institute for Research on Aging, Novato, United States
    2. Department of Urology, University of California, San Francisco, San Francisco, United States

    Contribution

    Conceptualization, Resources, Supervision, Funding acquisition, Validation, Investigation, Visualization, Methodology, Writing – original draft, Project administration, Writing – review and editing

    For correspondence

    Pkapahi@buckinstitute.org

    Competing interests

    Reviewing editor, eLife

    "This ORCID iD identifies the author of this article:" 0000-0002-5629-4947

• 1,408

  Page views

• 261

  Downloads

• 1

  Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.